|
| 33288543 | Integration of the Transcriptome and Genome-Wide Landscape of BRD2 and BRD4 Binding Motifs Identifies Key Superenhancer Genes and Reveals the Mechanism of Bet Inhibitor Action in Rheumatoid Arthritis Synovial Fibroblasts. | Journal of Immunology | 2021 |
| 34279934 | Gut-Restricted Selective Cyclooxygenase-2 (COX-2) Inhibitors for Chemoprevention of Colorectal Cancer. | Journal of Medicinal Chemistry | 2021 |
| 31088836 | DFMO and 5-Azacytidine Increase M1 Macrophages in the Tumor Microenvironment of Murine Ovarian Cancer. | Cancer Res | 2019 |
| 29765031 | Comprehensive epigenetic landscape of rheumatoid arthritis fibroblast-like synoviocytes. | Nat Commun | 2018 |
| 30138347 | A mechanism of T cell dependent selection of antigen engaged Germinal Center B cells. | PLoS ONE | 2018 |
| 30181297 | Reply to Haffner et al.: DNA hypomethylation renders tumors more immunogenic. | Proc Natl Acad Sci U S A | 2018 |
| 29203668 | Epigenetic therapy activates type I interferon signaling in murine ovarian cancer to reduce immunosuppression and tumor burden. | Proc Natl Acad Sci U S A | 2017 |
| 29127145 | TIM-3 Engagement Promotes Effector Memory T Cell Differentiation of Human Antigen-Specific CD8 T Cells by Activating mTORC1. | Journal of Immunology | 2017 |
| 23708506 | Lapatinib inhibits the growth of esophageal squamous cell carcinoma and synergistically interacts with 5-fluorouracil in patient-derived xenograft models. | Oncology Reports | 2013 |
| 23251242 | Loss and reduced expression of PTEN correlate with advanced-stage gastric carcinoma. | Experimental and Therapeutic Medicine (discontinued) | 2013 |
| 22169769 | Comprehensive predictive biomarker analysis for MEK inhibitor GSK1120212. | Molecular Cancer Therapeutics | 2012 |
| 22892846 | Analysis of glutamine dependency in non-small cell lung cancer: GLS1 splice variant GAC is essential for cancer cell growth. | Cancer Biology and Therapy | 2012 |
| 22421194 | Detection of tumor PIK3CA status in metastatic breast cancer using peripheral blood. | Clin Cancer Res | 2012 |
| 22949843 | Combined phosphatase and tensin homolog (PTEN) loss and fatty acid synthase (FAS) overexpression worsens the prognosis of Chinese patients with hepatocellular carcinoma. | International Journal of Molecular Sciences | 2012 |
| 22003129 | Subtype and pathway specific responses to anticancer compounds in breast cancer. | Proc Natl Acad Sci U S A | 2012 |
| 21600279 | Mutation and copy number detection in human cancers using a custom genotyping assay. | Genomics | 2011 |
| 21762492 | High chromosome number in hematological cancer cell lines is a negative predictor of response to the inhibition of Aurora B and C by GSK1070916. | Journal of Translational Medicine | 2011 |
| 21987798 | Mutation of a single allele of the cancer susceptibility gene BRCA1 leads to genomic instability in human breast epithelial cells. | Proc Natl Acad Sci U S A | 2011 |
| 20406975 | Molecular target class is predictive of in vitro response profile. | Cancer Research | 2010 |
| 20571075 | Sensitivity of cancer cells to Plk1 inhibitor GSK461364A is associated with loss of p53 function and chromosome instability. | Mol Cancer Ther | 2010 |
| 20562907 | Deletion of p53 in human mammary epithelial cells causes chromosomal instability and altered therapeutic response. | Oncogene | 2010 |
| 20382522 | Catalogue, cause, complexity and cure; the many uses of cancer genome sequence. | Current Opinion in Genetics and Development | 2010 |
| 19843859 | Deletion of PTEN promotes tumorigenic signaling, resistance to anoikis, and altered response to chemotherapeutic agents in human mammary epithelial cells. | Cancer Res | 2009 |
| 19196980 | Knockin of mutant PIK3CA activates multiple oncogenic pathways. | Proc Natl Acad Sci U S A | 2009 |
| 18162533 | Tamoxifen-stimulated growth of breast cancer due to p21 loss. | Proc Natl Acad Sci U S A | 2008 |
| 18630893 | Identification and validation of human DNA ligase inhibitors using computer-aided drug design. | Journal of Medicinal Chemistry | 2008 |
| 17082796 | Persistent mismatch repair deficiency following targeted correction of hMLH1. | Cancer Gene Ther | 2007 |
| 17611398 | P21 gene knock down does not identify genetic effectors seen with gene knock out. | Cancer Biol Ther | 2007 |
| 17332347 | High-throughput screening identifies novel agents eliciting hypersensitivity in Fanconi pathway-deficient cancer cells. | Cancer Research | 2007 |
| 17438369 | The RUNX2 transcription factor cooperates with the YES-associated protein, YAP65, to promote cell transformation. | Cancer Biology and Therapy | 2007 |
| 17875684 | Knock-in of mutant K-ras in nontumorigenic human epithelial cells as a new model for studying K-ras mediated transformation. | Cancer Res | 2007 |
| 16423997 | De novo CpG island methylation in human cancer cells. | Cancer Res | 2006 |
| 16959974 | The consensus coding sequences of human breast and colorectal cancers. | Science | 2006 |
| 16619041 | Interleukin-1 alpha mediates the growth proliferative effects of transforming growth factor-beta in p21 null MCF-10A human mammary epithelial cells. | Oncogene | 2006 |
| 16449998 | Mutation of the PIK3CA oncogene in human cancers. | Br J Cancer | 2006 |
| 16541319 | Physiologic estrogen receptor alpha signaling in non-tumorigenic human mammary epithelial cells. | Breast Cancer Res Treat | 2006 |
| 16982740 | MCT-1 protein interacts with the cap complex and modulates messenger RNA translational profiles. | Cancer Res | 2006 |
| 15956261 | Identification of compounds that inhibit growth of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine-resistant cancer cells. | Mol Cancer Ther | 2005 |
| 15608513 | Duel nature of TGF-beta signaling: tumor suppressor vs. tumor promoter. | Curr Opin Oncol | 2005 |
| 16007089 | Distinct epigenetic changes in the stromal cells of breast cancers. | Nat Genet | 2005 |
| 14726675 | p21(WAF1/CIP1) mediates the growth response to TGF-beta in human epithelial cells. | Cancer Biol Ther | 2004 |
| 15254419 | The PIK3CA gene is mutated with high frequency in human breast cancers. | Cancer Biol Ther | 2004 |
| 12697822 | The methyl-CpG binding protein MBD1 interacts with the p150 subunit of chromatin assembly factor 1. | Mol Cell Biol | 2003 |
| 12559178 | Histone modifications and silencing prior to DNA methylation of a tumor suppressor gene. | Cancer Cell | 2003 |
| 11932749 | DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. | Nature | 2002 |
| 11779840 | Enzymatic regional methylation assay: a novel method to quantify regional CpG methylation density. | Genome Res | 2002 |
| 11257100 | Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer. | Hum Mol Genet | 2001 |
| 11427539 | Dnmt3a and Dnmt3b are transcriptional repressors that exhibit unique localization properties to heterochromatin. | J Biol Chem | 2001 |
| 11420732 | DNA methylation, chromatin inheritance, and cancer. | Oncogene | 2001 |
| 10913614 | Decreased expression of the gut-enriched Krüppel-like factor gene in intestinal adenomas of multiple intestinal neoplasia mice and in colonic adenomas of familial adenomatous polyposis patients. | FEBS Letters | 2000 |